Could cause temporary or reversible harm; serious harm is unlikely.
Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.
| Brand name | PAIN RELIEVER |
| Generic name | ACETAMINOPHEN |
| Active ingredient(s) | ACETAMINOPHEN |
| Distributed by / for | Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015; |
| NDC | 0363-9947-35 |
| Full product label | Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200 Wilmot Rd, Deerfield, IL 60015; NDC 0363-9947-35. |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Distribution | The recalled product was distributed to one Retail Distributor (Walgreens) who further distributed Nationwide in the USA. |
| Quantity | 87,360 bottles |
| Recall initiated | 2023-05-22 |
| Report date | 2023-05-31 |
| Recall completed | — |
| Recall number | D-0765-2023 |
| Classification | Class II |
| FDA status | Completed |
| Origin on file | East Windsor NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗